rxstatShortages › Zolpidem

Zolpidem (Sublinox) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 29, 2026

Some Zolpidem products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 20, 2026.

A sedative used for the short-term treatment of insomnia.

Products affected
2 / 8
In shortage since
Feb 26, 2026
Est. full return
Nov 20, 2026
Reports on file
30
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
JAMP ZOLPIDEM ODT
5MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02540592 · since Jun 30, 2026, est. end Nov 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP ZOLPIDEM ODT
10MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02540606 · since Feb 26, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Resolved
SUBLINOX
10MG · TABLET (ORALLY DISINTEGRATING) · BAUSCH HEALTH, CANADA INC.
DIN 02370433 · ended Dec 15, 2025 · Missing/ Waiting on Documents from Supplier
Resolved
SUBLINOX
5MG · TABLET (ORALLY DISINTEGRATING) · BAUSCH HEALTH, CANADA INC.
DIN 02391678 · ended Jul 16, 2025 · issue with packaging
Resolved
APO-ZOLPIDEM ODT
10MG · TABLET (ORALLY DISINTEGRATING) · APOTEX INC
DIN 02434946 · ended Feb 6, 2025 · Disruption of the manufacture of the drug.
Resolved
SUBLINOX
5MG · TABLET (ORALLY DISINTEGRATING) · BAUSCH HEALTH, CANADA INC.
DIN 02391678 · ended Jan 3, 2025 · Delay in shipping of the drug.
Resolved
APO-ZOLPIDEM ODT
10MG · TABLET (ORALLY DISINTEGRATING) · APOTEX INC
DIN 02434946 · ended Dec 5, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ZOLPIDEM ODT
5MG · TABLET (ORALLY DISINTEGRATING) · APOTEX INC
DIN 02436159 · ended Oct 24, 2024 · Disruption of the manufacture of the drug.
Avoided
SUBLINOX
5MG · TABLET (ORALLY DISINTEGRATING) · BAUSCH HEALTH, CANADA INC.
DIN 02391678 · ended Oct 1, 2024 · Delay in shipping of the drug.
Resolved
PMS-ZOLPIDEM ODT
10MG · TABLET (ORALLY DISINTEGRATING) · PHARMASCIENCE INC
DIN 02436183 · ended Sep 29, 2024 · Disruption of the manufacture of the drug.
Resolved
PMS-ZOLPIDEM ODT
5MG · TABLET (ORALLY DISINTEGRATING) · PHARMASCIENCE INC
DIN 02436175 · ended Sep 11, 2024 · Disruption of the manufacture of the drug.
Resolved
SUBLINOX
10MG · TABLET (ORALLY DISINTEGRATING) · BAUSCH HEALTH, CANADA INC.
DIN 02370433 · ended Aug 19, 2024 · Delay in shipping of the drug.

Showing 12 of 30 reports. All reports are on file with Health Canada.

What's happening

Zolpidem is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Zolpidem is classified under “HYPNOTICS AND SEDATIVES” (ATC N05CF).

Recent changes

Common questions

What is Zolpidem used for?

A sedative used for the short-term treatment of insomnia.

When will Zolpidem be back in stock in Canada?

The latest manufacturer estimate is Nov 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Zolpidem in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (hypnotics and sedatives)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.